Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS04 - Industry Symposium Sponsored by Lilly Oncology: Implementing Precision Oncology in the Clinic: Diagnostic Challenges and Best Practices

    • 13:00 - 14:00
    • 1/28/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS04.01 - Chair’s Welcome

      13:00 - 13:04  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

    • +

      IS04.02 - Introduction to the Topic - A Brief Overview of the 15-Year Journey of Biomarker Driven Management of NSCLC

      13:04 - 13:10  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

    • +

      IS04.07 - Symposium Close

      14:00 - 14:00  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • +

      FP14.05 - LIBRETTO-431: Selpercatinib in Treatment-Naïve Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).

      00:00 - 00:00  |  Presenter: Koichi Goto

      • Abstract

      Loading...

    • +

      FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenter: Herbert H Loong

      • Abstract

      Loading...

  • +

    P02 - Diagnostics and Interventional Pulmonology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Diagnostics and Interventional Pulmonology
    • +

      P02.03 - Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.

      00:00 - 00:00  |  Presenter: Tetsuya Sakai

      • Abstract

      Loading...

  • +

    P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      P15.03 - A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC

      00:00 - 00:00  |  Presenter: Koichi Goto

      • Abstract

      Loading...

  • +

    P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P75.01 - Activity of Brigatinib in Alectinib-Resistant ALK-Positive NSCLC According to ALK Plasma Mutation Status From J-ALTA Trial

      00:00 - 00:00  |  Presenter: Toyoaki Hida

      • Abstract

      Loading...

  • +

    P89 - Targeted Therapy - Clinically Focused - Translational

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P89.06 - Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer

      00:00 - 00:00  |  Presenter: Shingo Matsumoto

      • Abstract

      Loading...

  • +

    OA04 - New Data from Rare EGFR Alterations

    • 11:45 - 12:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Targeted Therapy - Clinically Focused
    • +

      OA04.04 - Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer

      11:55 - 12:05  |  Presenter: Joshua K. Sabari

      • Abstract

      Loading...

  • +

    IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC

      13:20 - 13:40  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

  • +

    IS15 - Industry Symposium Sponsored by Amoy: Lung Cancer Biomarker Panel Testing

    • 13:00 - 14:00
    • 1/31/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS15.03 - Biomarker Panel Testing: PCR Panel vs NGS Panel

      13:21 - 13:39  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation

  • +

    MA11 - Expanding Targetable Genetic Alterations in NSCLC

    • 14:15 - 15:15
    • 1/31/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Targeted Therapy - Clinically Focused
    • +

      MA11.02 - Chair

      14:15 - 14:15  |  Presenter: Koichi Goto

      • Abstract

      No abstract available for this presentation